Recent Stories
American Biotech — The Future Can’t Be Won Without It.RSI is AI Building AI. What DC needs to know about it. Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: Robots

The Wave

Senatein sessionHousein session
Refreshed just now
Hill

GAO's Science & Tech Spotlight finds the FDA has authorized no AI chatbot for mental health care and flags sycophancy, unproven efficacy, and regulatory gaps for general-purpose and purpose-built chatbots.

Why it’s here: GAO spotlight on AI chatbots for mental health covers FDA authorization status, federal and state regulation gaps, and accountability questions, squarely within AI policy and health-regulation concerns for a DC audience.

Trace across the board

Item

Connected

11 links

About

  • Food and Drug Administration
  • GAO

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy

GAO's Science & Tech Spotlight finds the FDA has authorized no AI chatbot for mental health care and flags sycophancy, unproven efficacy, and regulatory gaps for general-purpose and purpose-built chatbots. — The Wave